75 related articles for article (PubMed ID: 23638089)
1. Association between SPARC mRNA expression, prognosis and response to neoadjuvant chemotherapy in early breast cancer: a pooled in-silico analysis.
Azim HA; Singhal S; Ignatiadis M; Desmedt C; Fumagalli D; Veys I; Larsimont D; Piccart M; Michiels S; Sotiriou C
PLoS One; 2013; 8(4):e62451. PubMed ID: 23638089
[TBL] [Abstract][Full Text] [Related]
2. EXPRESSION OF SPP1 AND SPARC GENES IN TUMOR TISSUE OF PATIENTS WITH BREAST CANCER.
Chekhun V; Pavlova A; Zadvornyi T; Borikun T; Naleskina L; Mushii O; Bazas V; Lukianova N
Exp Oncol; 2024 May; 46(1):13-21. PubMed ID: 38852057
[TBL] [Abstract][Full Text] [Related]
3. BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.
Aglan SA; Awad AM; Elwany YN; Shawky S; Salam RMA; Omar RS; Ghazala RAM; Soliman NA; Khedr MI; Kandil LS; Sultan M; Hamed Y; Kandil NS
Mol Genet Genomics; 2024 May; 299(1):56. PubMed ID: 38787424
[TBL] [Abstract][Full Text] [Related]
4. Osteonectin (SPARC) prognostic value in prostate cancer.
Chekhun V; Borikun T; Zadvornyi T; Mushii O; Stakhovsky E; Vitruk Y; Lukianova N
Pathol Res Pract; 2024 Feb; 254():155053. PubMed ID: 38199134
[TBL] [Abstract][Full Text] [Related]
5. Patient-specific analysis of co-expression to measure biological network rewiring in individuals.
Wei L; Xin Y; Pu M; Zhang Y
Life Sci Alliance; 2024 Feb; 7(2):. PubMed ID: 37977656
[TBL] [Abstract][Full Text] [Related]
6. Expression of secreted protein acidic and rich in cysteine (SPARC) in breast cancer and response to neoadjuvant chemotherapy.
Lindner JL; Loibl S; Denkert C; Ataseven B; Fasching PA; Pfitzner BM; Gerber B; Gade S; Darb-Esfahani S; Sinn BV; Huober J; Engels K; Tesch H; Karn T; Pommerenke F; Liedtke C; Untch M; Müller V; Rack B; Schem C; von Minckwitz G
Ann Oncol; 2015 Jan; 26(1):95-100. PubMed ID: 25355716
[TBL] [Abstract][Full Text] [Related]
7. PIK3CA mutations are associated with decreased benefit to neoadjuvant human epidermal growth factor receptor 2-targeted therapies in breast cancer.
Majewski IJ; Nuciforo P; Mittempergher L; Bosma AJ; Eidtmann H; Holmes E; Sotiriou C; Fumagalli D; Jimenez J; Aura C; Prudkin L; Díaz-Delgado MC; de la Peña L; Loi S; Ellis C; Schultz N; de Azambuja E; Harbeck N; Piccart-Gebhart M; Bernards R; Baselga J
J Clin Oncol; 2015 Apr; 33(12):1334-9. PubMed ID: 25559818
[TBL] [Abstract][Full Text] [Related]
8. The AURORA initiative for metastatic breast cancer.
Zardavas D; Maetens M; Irrthum A; Goulioti T; Engelen K; Fumagalli D; Salgado R; Aftimos P; Saini KS; Sotiriou C; Campbell P; Dinh P; von Minckwitz G; Gelber RD; Dowsett M; Di Leo A; Cameron D; Baselga J; Gnant M; Goldhirsch A; Norton L; Piccart M
Br J Cancer; 2014 Nov; 111(10):1881-7. PubMed ID: 25225904
[TBL] [Abstract][Full Text] [Related]
9. Secreted Protein Acidic and Rich in Cysteine (
Arqueros C; Salazar J; Gallardo A; Andrés M; Tibau A; Lidia Bell O; Artigas A; Lasa A; Ramón Y Cajal T; Lerma E; Barnadas A
Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137452
[TBL] [Abstract][Full Text] [Related]
10. SPARC: a potential target for functional nanomaterials and drugs.
Jiang S; Sun HF; Li S; Zhang N; Chen JS; Liu JX
Front Mol Biosci; 2023; 10():1235428. PubMed ID: 37577749
[TBL] [Abstract][Full Text] [Related]
11. SPARC in cancer-associated fibroblasts is an independent poor prognostic factor in non-metastatic triple-negative breast cancer and exhibits pro-tumor activity.
Alcaraz LB; Mallavialle A; Mollevi C; Boissière-Michot F; Mansouri H; Simony-Lafontaine J; Laurent-Matha V; Chardès T; Jacot W; Turtoi A; Roger P; Guiu S; Liaudet-Coopman E
Int J Cancer; 2023 Mar; 152(6):1243-1258. PubMed ID: 36346290
[TBL] [Abstract][Full Text] [Related]
12. The Role of Extracellular Matrix Proteins in Breast Cancer.
Lepucki A; Orlińska K; Mielczarek-Palacz A; Kabut J; Olczyk P; Komosińska-Vassev K
J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268340
[TBL] [Abstract][Full Text] [Related]
13. Investigating the relationship between secreted protein acidic and rich in cysteine expression level and therapeutic efficacy of nab-paclitaxel: a meta-analysis.
Zhou X; Zhang L; Qierang C; Huang M; Yang X; Li L; Jiang J
Transl Cancer Res; 2021 Feb; 10(2):876-885. PubMed ID: 35116417
[TBL] [Abstract][Full Text] [Related]
14. The pathological complete response and secreted protein acidic and rich in cysteine expression in patients with breast cancer receiving neoadjuvant nab-paclitaxel chemotherapy.
Nakazawa Y; Nakazawa S; Kurozumi S; Ogino M; Koibuchi Y; Odawara H; Oyama T; Horiguchi J; Fujii T; Shirabe K
Oncol Lett; 2020 Apr; 19(4):2705-2712. PubMed ID: 32218821
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment.
Rybinska I; Sandri M; Bianchi F; Orlandi R; De Cecco L; Gasparini P; Campiglio M; Paolini B; Sfondrini L; Tagliabue E; Triulzi T
Cells; 2020 Feb; 9(2):. PubMed ID: 32069815
[TBL] [Abstract][Full Text] [Related]
16. Association of SPARC gene polymorphisms rs3210714 and rs7719521 with VEGF expression and utility of Nottingham Prognostic Index scoring in breast cancer in a sample of Egyptian women.
Bawazeer S; Sabry D; Mahmoud RH; Elhanbuli HM; Yassen NN; Abdelhafez MN
Mol Biol Rep; 2018 Dec; 45(6):2313-2324. PubMed ID: 30259245
[TBL] [Abstract][Full Text] [Related]
17. Preoperative neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for operable breast cancer: a multicenter phase II trial.
Futamura M; Nagao Y; Ishihara K; Takeuchi M; Nakada T; Kawaguchi Y; Asano M; Kumazawa I; Shiroko T; Morimitsu K; Mori R; Nawa M; Shimokawa T; Yoshida K
Breast Cancer; 2017 Jul; 24(4):615-623. PubMed ID: 28050738
[TBL] [Abstract][Full Text] [Related]
18. High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer.
Wang T; Srivastava S; Hartman M; Buhari SA; Chan CW; Iau P; Khin LW; Wong A; Tan SH; Goh BC; Lee SC
Oncotarget; 2016 Aug; 7(34):55155-55168. PubMed ID: 27487140
[TBL] [Abstract][Full Text] [Related]
19. SPARC overexpression in primary tumors correlates with disease recurrence and overall survival in patients with triple negative breast cancer.
Zhu A; Yuan P; Du F; Hong R; Ding X; Shi X; Fan Y; Wang J; Luo Y; Ma F; Zhang P; Li Q; Xu B
Oncotarget; 2016 Nov; 7(47):76628-76634. PubMed ID: 27421134
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
